These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3009384)

  • 1. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
    Mehtar S; Croft RJ; Hilas A
    J Antimicrob Chemother; 1986 Mar; 17(3):389-96. PubMed ID: 3009384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D; Esposito S; Barba D; Ruffilli MP
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
    Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
    Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections].
    Kobayashi H; Takamura K; Kono K; Nihei T; Saito A; Nakayama I; Ujiie A; Yajima O; Tango M; Tomizawa M
    Kansenshogaku Zasshi; 1985 Jul; 59(7):708-48. PubMed ID: 2997342
    [No Abstract]   [Full Text] [Related]  

  • 5. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with sulbactam/ampicillin in the pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
    Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
    Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
    Plouffe JF
    Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L; Milson JA; Knirsch AK; Greenhalgh K
    Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL
    Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sulbactam plus ampicillin in gynecologic infections.
    Giamarellou H; Trouvas G; Avlami A; Aravantinos D; Daikos GK
    Rev Infect Dis; 1986; 8 Suppl 5():S579-82. PubMed ID: 3026007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
    Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.